Get started
Author

Kangjun Yu

RETRACTED ARTICLE: High Expression of RIOK2 and NOB1 Predict Human Non-small Cell Lung Cancer Outcomes
2016 · Kun Liu, Hong-Lin Chen, et al. · Scientific Reports · 36
PDF
miR‑145 inhibits human non‑small-cell lung cancer growth by dual-targeting RIOK2 and NOB1
2018 · Kun Liu, Honglin Chen, et al. · International Journal of Oncology · 32
PDF
Curcumin attenuates myocardial ischemia-reperfusion injury
2017 · Kun Liu, Honglin Chen, et al. · Oncotarget · 31
PDF
DISC1 overexpression promotes non-small cell lung cancer cell proliferation
2017 · Shuo Wang, Ying-Ying Chen, et al. · Oncotarget · 12
PDF
The Expression and Clinical Value of miR-221 and miR-320 in the Plasma of Women with Gestational Diabetes Mellitus
2022 · Sanqiang Niu, Kangjun Yu, et al. · Clinical Laboratory · 3
Construct a nomogram prediction and evaluation of influencing factors of adverse pregnancy outcomes in GDM patients based on plasma miR-144-3p levels
2025 · Sanqiang Niu, Pengwen Wu, et al. · Frontiers in Endocrinology · 2
PDF
Eclampsia as the First Manifestation of Primary Hyperparathyroidism: a Case Report
2023 · Sanqiang Niu, Kangjun Yu, et al. · Clinical Laboratory · 2
Prognostic and Immunomodulatory Roles of BNIP3 in Osteosarcoma Revealed by Integrated Single‐Cell and Bulk Transcriptomic Profiling
2026 · Jiamiao Li, Wei Wang, et al. · International Journal of Genomics · 1
Expression and clinical significance of miR-377-3p and cyclin G2 in preeclampsia patients
2025 · Sanqiang Niu, Kangjun Yu, et al. · BMC Pregnancy and Childbirth
PDF
Retraction Note: High Expression of RIOK2 and NOB1 Predict Human Non-small Cell Lung Cancer Outcomes
2023 · Kun Liu, Hong-Lin Chen, et al. · Scientific Reports
PDF
Works count: 10
Citation count: 119
H-index: 4
I10-index: 4
Year
Topic
Type